Discovery and ADMET: Where Are We Now

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|4|467-481

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.4, 2011-02, pp. : 467-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intermediate care – where are we now?

By Harari Danielle  

Clinical Medicine, Vol. 2, Iss. 5, 2002-09 ,pp. : 477-479

Royal College Of Physicians

Access to resources Recommend Favorite

The Second Window of Preconditioning (SWOP) Where Are We Now?

By Hausenloy Derek   Yellon Derek  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 235-254

Springer Publishing Company

Access to resources Recommend Favorite

Intraperitoneal Chemotherapy for Ovarian Cancer: Where Are We Now?

By Singhal Pankaj   Lele Shashikant  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 9, 2006-10 ,pp. : 941-946

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Antiatherosclerotic Effects of ACE Inhibitors: Where Are We Now?

By Lonn E.  

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 5, 2001-01 ,pp. : 315-320

Adis International

Access to resources Recommend Favorite

Editorial: [Hot Topic: Molecular Pathology in Therapeutics: Where are We Now, and Where are We Going?]

By  

Current Drug Targets, Vol. 13, Iss. 12, 2012-11 ,pp. : 1473-1474

Bentham Science Publishers

Access to resources Recommend Favorite